DR. RANDALL WHITCOMB, M.D.
Osteopathic Medicine at High Hollow Dr, Ann Arbor, MI
License number
Michigan 4301060603
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
1527 High Hollow Dr, Ann Arbor, MI 48103
Phone
(734) 276-9007
Personal information
See more information about RANDALL WHITCOMB at radaris.comName
Address
Phone
5333 Mcauley Dr, Ypsilanti, MI 48197
1527 High Hollow Dr, Scio Township, MI 48103
Ann Arbor, MI
Professional information
See more information about RANDALL WHITCOMB at trustoria.com
Sulfonylurea-Glitazone Combinations For Diabetes
Sulfonylurea-Glitazone Combinations For Diabetes
US Patent:
5859037, Jan 12, 1999
Filed:
Nov 13, 1997
Appl. No.:
8/970057
Inventors:
Randall Wayne Whitcomb - Ann Arbor MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 31425, A61K 31175
US Classification:
514369
Abstract:
Combinations of a sulfonylurea antidiabetic agent and a glitazone antidiabetic agent are useful for treating diabetes mellitus and improving glycemic control.
Sulfonylurea-Glitazone Combinations For Diabetes
Sulfonylurea-Glitazone Combinations For Diabetes
US Patent:
5972973, Oct 26, 1999
Filed:
Oct 16, 1998
Appl. No.:
9/173911
Inventors:
Randall Wayne Whitcomb - Ann Arbor MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 3155, A61K 31495, A61K 3144, A61K 3147
US Classification:
514342
Abstract:
Combinations of a sulfonylurea antidiabetic agent and a glitazone antidiabetic agent are useful for treating diabetes mellitus and improving glycemic control.
Combinations For Diabetes
Combinations For Diabetes
US Patent:
6011049, Jan 4, 2000
Filed:
Nov 9, 1998
Appl. No.:
9/189132
Inventors:
Randall Wayne Whitcomb - Ann Arbor MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 3144, A61K 31425, A61K 31175, A61K 31155
US Classification:
514369
Abstract:
Combinations of a glitazone antidiabetic agent and a biguanide antidiabetic agent, and optionally a sulfonylurea antidiabetic agent, are useful for treating diabetes mellitus and improving glycemic control.